Company Dendreon Corporation
Equities
US24823Q1076
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Endo : Drugmaker Valeant close to buying Salix - source | RE |
2015 | Dendreon : Valeant secures financing for potential Salix bid: Bloomberg | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 158,716,893 | 153,327,147 ( 96.60 %) | 0 | 96.60 % |
Company contact information
Dendreon Corp.
1208 Eastlake Avenue East
98102, Seattle
+206-256-4545
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- Stock
- Company Dendreon Corporation